Depression is a highly prevalent mental health condition. Because many patients fail to respond to standard therapies, there is a pressing need for alternative approaches. Recently, administration of ...
WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional ...
A single dose of an investigational lysergic acid diethylamide (LSD)-based medication known as MM120 (lysergide D-tartrate, Mind Medicine Inc [MindMed]) was associated with a rapid and significant ...
A mid-stage study of a pharmaceutical version of the psychedelic LSD reported the drug might help alleviate anxiety symptoms for up to three months, advancing a potential treatment for the most common ...
Psychedelic-assisted therapy combines the use of psychedelic substances with psychotherapy for individuals suffering from post-traumatic stress disorder, obsessive-compulsive disorder, depression, or ...
New research published in Nature Neuroscience provides evidence that a non-hallucinogenic analog of psychedelic drugs can stimulate brain cell growth through the same molecular pathway as traditional ...
Ibogaine is a Schedule 1 drug in America with no legal medical uses. But the results, several athletes say, are game-changing ...
WASHINGTON – LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback